TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Renapharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
20,288
|
20,153
|
16,799 |
Financial expenses |
52
|
21
|
80 |
Earnings before taxes |
4,435
|
4,928
|
5,789 |
EBITDA |
4,817
|
5,278
|
6,703 |
Total assets |
29,730
|
24,816
|
18,899 |
Current assets |
14,566
|
12,991
|
7,073 |
Current liabilities |
6,491
|
5,151
|
1,526 |
Equity capital |
17,797
|
13,295
|
9,104 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
4
![]() |
4
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
59.9%
|
53.6%
|
48.2% |
Turnover per employee |
5,072
|
5,038
|
5,600 |
Profit as a percentage of turnover |
21.9%
|
24.5%
|
34.5% |
Return on assets (ROA) |
15.1%
|
19.9%
|
31.1% |
Current ratio |
224.4%
|
252.2%
|
463.5% |
Return on equity (ROE) |
24.9%
|
37.1%
|
63.6% |
Change turnover |
31
|
4,715
|
4,274 |
Change turnover % |
0%
|
31%
|
34% |
Chg. No. of employees |
0
|
1
|
-1 |
Chg. No. of employees % |
0%
|
33%
|
-25% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.